Beta adrenergic receptor blocking drugs as physiological tools in clinical medicine.
D001007:Anxiety / Q000503:physiopathology; D001249:Asthma / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D001810:Blood Volume / Q000187:drug effects; D001920:Bradykinin / Q000494:pharmacology; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy; D002395:Catecholamines / Q000494:pharmacology; D004644:Emotions / Q000503:physiopathology; D005239:Fear / Q000503:physiopathology; D005260:Female; D006331:Heart Diseases / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects*; D006439:Hemodynamics; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D006980:Hyperthyroidism / Q000188:drug therapy*; D000860:Hypoxia / Q000503:physiopathology; D008660:Metabolism / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy; D010673:Pheochromocytoma / Q000188:drug therapy; D005082:Physical Exertion; D011247:Pregnancy / Q000187:drug effects*; D011674:Pulse / Q000187:drug effects; D013565:Sympatholytics / Q000627:therapeutic use*; D014599:Uterus / Q000187:drug effects
D002395:Catecholamines; D013565:Sympatholytics; D001920:Bradykinin